HCA Healthcare, Inc. (HCA)
Healthcare · Medical - Care Facilities · Data as of 2026-10-22
Bottom line
HCA is trading at a discount to its history, near its historical support zone, and recent volume shows no clear direction. Historically, this combination has been a favourable starting point for further research. Past patterns are not a guarantee of future results.
Valuation — Trading at a discount to its history (Green)
HCA trades at 16× earnings, roughly in line with its own 5-year average of 14× and below similar healthcare companies we track (28×, 53 peers). Historically this has been on the cheaper side for the stock. Its free-cash-flow yield is about 6.0%. Growth is slower than its 3-year pace, which deserves some caution. Its current multiple sits around the 66th percentile of its own last five years — toward the high end of its own range. Its fundamentals scored 7 of 9 on a standard year-over-year quality checklist — most of the underlying trends improved last fiscal year.
Price zones — Near its historical support zone (Green)
At $467.31, the stock is close to the lower end of its recent range. Over the past year HCA has traded between $353.99 and $556.52; its historical support zone sits near $444.67 and resistance near $556.52. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $353.99–$556.52 · 50-day average $430.37 · 200-day average $444.67
Money flow — No clear direction (Yellow)
Buying and selling volume in HCA have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 0.7× volume on down days over the last 30 sessions.
Dividends & company facts
HCA paid $3.06 a share in dividends over the past year — 0.65% of today's price — and has raised it in each of the last five years. It returned more through buybacks: $10.1 billion in fiscal 2025, about 10.0% of its market value.
- Dividend yield (12 months)
- 0.65%
- Paid over 12 months
- $3.06 a share
- Payout ratio
- 10.0%
- Buybacks
- 9.98% (fiscal 2025)
- Shares, past year
- -7.9%
- Revenue, 12 months
- $78.0B
- Profit, 12 months
- $6.8B
- Employees
- 320,000
- CEO
- Samuel N. Hazen
- Headquarters
- Nashville, TN
- Listed since
- 2011 · NYSE
About the company
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy.
Related stocks
一句话结论
HCA 相对自身历史处于折价水平，接近其历史支撑区，近期成交量没有明确方向。从历史来看，这样的组合是一个值得进一步研究的有利起点。过去的形态并不能保证未来的结果。
估值 — 相对自身历史处于折价水平
HCA 目前的市盈率为 16×，大致持平于其自身 5 年平均的 14×，并且低于我们追踪的同类Healthcare公司（28×，53 家）。从历史来看，这属于该股较便宜的一侧。其自由现金流收益率约为 6.0%。增速已慢于其 3 年的平均步伐，这一点值得留意。它当前的估值倍数大约位于自身过去五年分布的第 66 百分位——处于自身区间的偏高位置。在一套标准的逐年基本面核对清单上，它 9 项中通过了 7 项——上一财年多数底层趋势在改善。
价格区间 — 接近其历史支撑区
目前价格为 $467.31，接近其近期区间的下沿。过去一年 HCA 的价格在 $353.99 到 $556.52 之间波动；其历史支撑区在 $444.67 附近，阻力区在 $556.52 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 方向不明确
HCA 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 0.7×。
股息与公司概况
HCA 过去一年每股派息 3.06 美元，相当于当前股价的 0.65%，过去五年每年都有上调。它通过回购返还了更多：2025 财年回购 101亿美元，约占市值的 10.0%。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.